The Firm is representing EQT IX fund and funds affiliated with the Private Equity business within Goldman Sachs Asset Management in their announced definitive agreement to acquire Parexel from Pamplona Capital Management LP for $8.5 billion. The transaction is subject to customary conditions, including receipt of applicable regulatory approvals.
Parexel supports the development of innovative new medicines to improve the health of patients. It provides services to help life sciences and biopharmaceutical clients everywhere transform scientific discoveries into new treatments. From decentralized clinical trials to regulatory consulting services to leveraging real world insights, Parexel’s therapeutic, technical and functional ability is underpinned by a deep conviction in what it does.
EQT is a purpose-driven global investment organization with more than €67 billion in assets under management across 26 active funds. EQT funds have portfolio companies in Europe, Asia-Pacific and the Americas with total sales of approximately €29 billion and more than 175,000 employees. EQT works with portfolio companies to achieve sustainable growth, operational excellence and market leadership.
Goldman Sachs Asset Management provides clients around the world with a dedicated partnership and focus on long-term performance. As the primary investing area within Goldman Sachs (NYSE: GS), Goldman Sachs Asset Management delivers investment and advisory services for the world’s leading institutions, financial advisors and individuals, drawing from its deeply connected global network and tailored expert insights, across every region and market—overseeing more than $2 trillion in assets under supervision worldwide as of March 31, 2021. Established in 1986, the Private Equity business within Goldman Sachs Asset Management has invested over $75 billion since inception.
The Simpson Thacher team for the transaction included Michael T. Holick, Katherine Krause, Patrick Naughton, Mark Myott, Frederick W.P. De Albuquerque, Sherry Shen, Juan Gonzalez, Megan Whitman, Cedric Karaoglan and Laura Yang (M&A); Eli Isak, Jennifer Hobbs, Catherine Burns and Alexander Kleinhaus-Resisi (Credit); David Rubinsky and Scott Schilson (Executive Compensation and Employee Benefits); Jonathan Goldstein, Benjamin Rippeon and Edward Grais (Tax); Adeeb Fadil and Noreen Lavan (Environmental); Lori Lesser and Samuel Watters (IP); Richard Jamgochian (Antitrust); Mick Tuesley, David Caldwell, Jennifer Ho and Christine Tillema (Regulatory); and Vanessa Burrows (Healthcare). Summer Associates Minaal Wickremesinghe, Andrew Pierce and Cara Anstey also provided valuable assistance.